Gerben BORST,Olaf van TELLINGEN,Moshe GILADI,Mark C. de GOOIJER,Paul L.G. SLANGEN
申请号：
US16593081
公开号：
US20200108031A1
申请日:
2019.10.04
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Viability of cancer cells (e.g., glioblastoma cells) can be reduced by administering ABT-751 to the cancer cells and applying an alternating electric field with a frequency between 100 and 400 kHz (e.g., 200 kHz) to the cancer cells. Notably, experiments show that the combination of ABT-751 and the alternating electric field produces synergistic results for certain glioblastoma cell lines.
